Xuemei Du

471 total citations
17 papers, 382 citations indexed

About

Xuemei Du is a scholar working on Oncology, Molecular Biology and Renewable Energy, Sustainability and the Environment. According to data from OpenAlex, Xuemei Du has authored 17 papers receiving a total of 382 indexed citations (citations by other indexed papers that have themselves been cited), including 8 papers in Oncology, 6 papers in Molecular Biology and 4 papers in Renewable Energy, Sustainability and the Environment. Recurrent topics in Xuemei Du's work include Peptidase Inhibition and Analysis (5 papers), Protease and Inhibitor Mechanisms (4 papers) and CO2 Reduction Techniques and Catalysts (3 papers). Xuemei Du is often cited by papers focused on Peptidase Inhibition and Analysis (5 papers), Protease and Inhibitor Mechanisms (4 papers) and CO2 Reduction Techniques and Catalysts (3 papers). Xuemei Du collaborates with scholars based in United States, China and Canada. Xuemei Du's co-authors include Jeremy I. Levin, Thomas S. Rush, Jerauld S. Skotnicki, Yonghan Hu, Steve Tam, Jennifer R. Thomason, Jason Xiang, Jianchang Li, J.S. Skotnicki and Junjun Wu and has published in prestigious journals such as Angewandte Chemie International Edition, Advanced Functional Materials and Scientific Reports.

In The Last Decade

Xuemei Du

15 papers receiving 371 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Xuemei Du United States 9 162 137 128 112 37 17 382
Lawrence A. Reiter United States 15 358 2.2× 100 0.7× 66 0.5× 268 2.4× 21 0.6× 32 697
Grace E. Munie United States 14 212 1.3× 204 1.5× 222 1.7× 95 0.8× 59 1.6× 17 478
C. Michelle Dunaway United States 8 442 2.7× 210 1.5× 230 1.8× 146 1.3× 14 0.4× 8 654
Shuichiro Ito Japan 10 220 1.4× 107 0.8× 52 0.4× 38 0.3× 10 0.3× 15 412
W. Howard Roark United States 14 301 1.9× 106 0.8× 142 1.1× 210 1.9× 48 1.3× 19 639
Batool Shannan Germany 8 258 1.6× 330 2.4× 79 0.6× 38 0.3× 12 0.3× 11 544
Alison D. Findlay Australia 16 286 1.8× 57 0.4× 31 0.2× 364 3.3× 36 1.0× 27 765
Frances C. Nelson United States 11 200 1.2× 178 1.3× 164 1.3× 138 1.2× 35 0.9× 12 428
Moorthy S. S. Palanki United States 18 441 2.7× 110 0.8× 118 0.9× 297 2.7× 82 2.2× 28 818
Jennifer R. Thomason United States 11 195 1.2× 115 0.8× 124 1.0× 190 1.7× 43 1.2× 12 444

Countries citing papers authored by Xuemei Du

Since Specialization
Citations

This map shows the geographic impact of Xuemei Du's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Xuemei Du with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Xuemei Du more than expected).

Fields of papers citing papers by Xuemei Du

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Xuemei Du. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Xuemei Du. The network helps show where Xuemei Du may publish in the future.

Co-authorship network of co-authors of Xuemei Du

This figure shows the co-authorship network connecting the top 25 collaborators of Xuemei Du. A scholar is included among the top collaborators of Xuemei Du based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Xuemei Du. Xuemei Du is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

17 of 17 papers shown
1.
Du, Xuemei, et al.. (2026). Introduction of the SiO 2 Buffer Layer Enables High CO Selectivity in Bicarbonate Electrolyzer. The Journal of Physical Chemistry Letters. 17(2). 679–684.
2.
Du, Xuemei, Xinmin Yang, Xin Chen, et al.. (2025). Covalency Regulation of Ru‐Based Solid Solutions by Iridium for Durable Proton Exchange Membrane Water Electrolysis at 2 A cm−2. Advanced Functional Materials. 35(42). 6 indexed citations
3.
Zhou, Wenting, Lin‐Hui Wang, Xue Zhang, et al.. (2025). A visualized machine learning model using noninvasive parameters to differentiate men with and without prostatic carcinoma before biopsy. Scientific Reports. 15(1). 27357–27357.
4.
Sun, Yan‐Hui, Junxiang Chen, Xuemei Du, et al.. (2024). Anchoring Cs+ Ions on Carbon Vacancies for Selective CO2 Electroreduction to CO at High Current Densities in Membrane Electrode Assembly Electrolyzers. Angewandte Chemie International Edition. 63(40). e202410802–e202410802. 13 indexed citations
5.
Wang, Junqing, Yulin Lin, Ru Ma, et al.. (2024). Potential treatment approaches for malignant peritoneal mesothelioma: in vivo and in vitro experimental study of natural killer cell immunotherapy. Cancer Biology and Medicine. 21(11). 1–17. 5 indexed citations
6.
Chen, Junxiang, Xuemei Du, Xin Chen, et al.. (2024). Anchoring Cs+ Ions on Carbon Vacancies for Selective CO2 Electroreduction to CO at High Current Densities in Membrane Electrode Assembly Electrolyzers. Angewandte Chemie. 136(40). 3 indexed citations
7.
Guo, Lei, et al.. (2022). Roller microneedles transdermal delivery of compound lidocaine cream for enhancing the analgesic effect: A randomized self‐controlled trial. Journal of Cosmetic Dermatology. 21(11). 5825–5836. 1 indexed citations
8.
Li, Wei, Yonghan Hu, Jianchang Li, et al.. (2009). 3,4-Disubstituted benzofuran P1′ MMP-13 inhibitors: Optimization of selectivity and reduction of protein binding. Bioorganic & Medicinal Chemistry Letters. 19(16). 4546–4550. 10 indexed citations
9.
Mayer, Scott C., Dan M. Berger, Diane H. Boschelli, et al.. (2008). Lead identification to generate 3-cyanoquinoline inhibitors of insulin-like growth factor receptor (IGF-1R) for potential use in cancer treatment. Bioorganic & Medicinal Chemistry Letters. 19(1). 62–66. 34 indexed citations
10.
Zask, Arie, Joshua A. Kaplan, Xuemei Du, et al.. (2005). Synthesis and SAR of diazepine and thiazepine TACE and MMP inhibitors. Bioorganic & Medicinal Chemistry Letters. 15(6). 1641–1645. 23 indexed citations
11.
Li, Jianchang, Thomas S. Rush, Wěi Li, et al.. (2005). Synthesis and SAR of highly selective MMP-13 inhibitors. Bioorganic & Medicinal Chemistry Letters. 15(22). 4961–4966. 55 indexed citations
12.
Hu, Yonghan, Jason Xiang, Martin DiGrandi, et al.. (2005). Potent, selective, and orally bioavailable matrix metalloproteinase-13 inhibitors for the treatment of osteoarthritis. Bioorganic & Medicinal Chemistry. 13(24). 6629–6644. 90 indexed citations
13.
Wu, Junjun, Thomas S. Rush, Rajeev Hotchandani, et al.. (2005). Identification of potent and selective MMP-13 inhibitors. Bioorganic & Medicinal Chemistry Letters. 15(18). 4105–4109. 60 indexed citations
14.
Wu, Junjun, Thomas S. Rush, Rajeev Hotchandani, et al.. (2005). Identification of Potent and Selective MMP‐13 Inhibitors.. ChemInform. 36(49). 1 indexed citations
15.
Zhang, Yuhua, Martin Hegen, Jun Xu, et al.. (2004). Characterization of (2R, 3S)-2-({[4-(2-butynyloxy)phenyl]sulfonyl}amino)-N,3-dihydroxybutanamide, a potent and selective inhibitor of TNF-α converting enzyme. International Immunopharmacology. 4(14). 1845–1857. 48 indexed citations
16.
Berger, Dan, Minu Dutia, Dennis Powell, et al.. (2003). Synthesis and evaluation of 4-Anilino-6,7-dialkoxy-3-quinolinecarbonitriles as inhibitors of kinases of the Ras-MAPK signaling cascade. Bioorganic & Medicinal Chemistry Letters. 13(18). 3031–3034. 25 indexed citations
17.
Albright, J. Donald & Xuemei Du. (2000). Synthesis of 1,4,5,6‐tetrahydropyrazolo[3,4‐d]pyrido[3,2‐b]azepine. Journal of Heterocyclic Chemistry. 37(1). 41–46. 8 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026